Search - tctmd.com

Displaying 1 - 20 of 1551

Sort: Relevancy | Date

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Daily News

Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD

Yael L. Maxwell

March 24, 2026

News Daily News

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

Yael L. Maxwell

March 12, 2026

News Daily News

HBR Common, Impactful Among All-Comer Acute MI Patients

Yael L. Maxwell

March 05, 2026

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Michael O'Riordan

March 03, 2026

News Conference News EAPCI 2026

SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry

Caitlin E. Cox

February 27, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US

Caitlin E. Cox

January 23, 2026

News Daily News

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

Caitlin E. Cox

January 20, 2026

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Yael L. Maxwell

December 09, 2025

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

Caitlin E. Cox

December 04, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Conference News AHA 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Yael L. Maxwell

November 13, 2025

Advertisement

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

March 2026 Dispatch for the CV Team

Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

HBR Common, Impactful Among All-Comer Acute MI Patients

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

SCAD-Related MI Not Just the Domain of Young Women: Serbian Registry

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

TCTMD’s Top 10 Most Popular Stories for January 2026

Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US

IVUS, OCT Each Bring Something to the Table for PCI in Complex Lesions: Meta-analysis

TCTMD’s Biggest News of 2025

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Frailty Extra Risky in Young Patients With Acute MI

TCTMD’s Top 10 Most Popular Stories for November 2025

Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content